Quanex Building Products Announces Fourth Quarter and Fiscal Year 2021 Results
Record Revenue Growth & Earnings in FY21
Balance Sheet & Liquidity Continue to Improve and Remain Strong
Board Authorizes New
The Company reported the following selected financial results:
Q4 2021 Earnings Release | |||||||||||||||||
Three Months Ended |
Twelve Months Ended |
||||||||||||||||
($ in millions, except per share data) | 2021 | 2020 | 2021 | 2020 | |||||||||||||
Gross Margin | |||||||||||||||||
Gross Margin % | 22.3% | 25.9% | 22.4% | 22.6% | |||||||||||||
Net Income | |||||||||||||||||
Diluted EPS | |||||||||||||||||
Adjusted Net Income | |||||||||||||||||
Adjusted Diluted EPS | |||||||||||||||||
Adjusted EBITDA | |||||||||||||||||
Adjusted EBITDA Margin % | 12.8% | 15.4% | 11.8% | 12.3% | |||||||||||||
Cash Provided by Operating Activities | |||||||||||||||||
Free Cash Flow |
(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and Free Cash Flow Reconciliation table for additional information)
“Our liquidity position has improved meaningfully over the past year, and our balance sheet is strong. We were able to pay down
Fourth Quarter and Fiscal 2021 Results Summary
Quanex reported net sales growth of 14.2% and 25.9% during the three months and twelve months ended
The decrease in earnings for the three months ended
Balance Sheet & Liquidity Update
As of
The Company’s liquidity increased to
Share Repurchases
Quanex’s Board authorized a
Quanex’s Board recently authorized a new
Outlook
Conference Call and Webcast Information
The Company has scheduled a conference call for
About Quanex
Non-GAAP Terminology Definitions and Disclaimers
Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement. Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance. Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with
Forward Looking Statements
Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended |
Twelve Months Ended |
||||||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||||||
Net sales | $ | 291,768 | $ | 255,405 | $ | 1,072,149 | $ | 851,573 | |||||||||
Cost of sales | 226,818 | 189,164 | 831,541 | 658,750 | |||||||||||||
Selling, general and administrative | 27,668 | 26,889 | 115,967 | 89,707 | |||||||||||||
Restructuring charges | - | 145 | 39 | 622 | |||||||||||||
Depreciation and amortization | 10,189 | 11,378 | 42,732 | 47,229 | |||||||||||||
Operating income | 27,093 | 27,829 | 81,870 | 55,265 | |||||||||||||
Interest expense | (542 | ) | (935 | ) | (2,530 | ) | (5,245 | ) | |||||||||
Other, net | 109 | 164 | 754 | 280 | |||||||||||||
Income before income taxes | 26,660 | 27,058 | 80,094 | 50,300 | |||||||||||||
Income tax expense | (5,762 | ) | (4,906 | ) | (23,114 | ) | (11,804 | ) | |||||||||
Net income | $ | 20,898 | $ | 22,152 | $ | 56,980 | $ | 38,496 | |||||||||
Earnings per common share, basic | $ | 0.63 | $ | 0.68 | $ | 1.72 | $ | 1.18 | |||||||||
Earnings per common share, diluted | $ | 0.62 | $ | 0.68 | $ | 1.70 | $ | 1.17 | |||||||||
Weighted average common shares outstanding: | |||||||||||||||||
Basic | 33,191 | 32,608 | 33,193 | 32,689 | |||||||||||||
Diluted | 33,454 | 32,811 | 33,495 | 32,821 | |||||||||||||
Cash dividends per share | $ | 0.08 | $ | 0.08 | $ | 0.32 | $ | 0.32 | |||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 40,061 | $ | 51,621 | ||||
Accounts receivable, net | 108,309 | 88,287 | ||||||
Inventories, net | 92,529 | 61,181 | ||||||
Prepaid and other current assets | 8,148 | 6,217 | ||||||
Total current assets | 249,047 | 207,306 | ||||||
Property, plant and equipment, net | 178,630 | 184,104 | ||||||
Operating lease right-of-use assets | 52,708 | 51,824 | ||||||
149,205 | 146,154 | |||||||
Intangible assets, net | 82,410 | 93,068 | ||||||
Other assets | 5,323 | 9,129 | ||||||
Total assets | $ | 717,323 | $ | 691,585 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 86,765 | $ | 77,335 | ||||
Accrued liabilities | 56,156 | 38,289 | ||||||
Income taxes payable | 6,038 | 6,465 | ||||||
Current maturities of long-term debt | 846 | 692 | ||||||
Current operating lease liabilities | 8,196 | 7,459 | ||||||
Total current liabilities | 158,001 | 130,240 | ||||||
Long-term debt | 52,094 | 116,728 | ||||||
Noncurrent operating lease liabilities | 45,367 | 44,873 | ||||||
Deferred pension and postretirement benefits | 4,737 | 10,923 | ||||||
Deferred income taxes | 21,965 | 19,116 | ||||||
Liabilities for uncertain tax positions | 1,388 | 522 | ||||||
Other liabilities | 13,989 | 13,424 | ||||||
Total liabilities | 297,541 | 335,826 | ||||||
Stockholders’ equity: | ||||||||
Common stock | 373 | 373 | ||||||
Additional paid-in-capital | 254,162 | 253,458 | ||||||
Retained earnings | 259,718 | 213,517 | ||||||
Accumulated other comprehensive loss | (21,770 | ) | (33,024 | ) | ||||
(72,701 | ) | (78,565 | ) | |||||
Total stockholders’ equity | 419,782 | 355,759 | ||||||
Total liabilities and stockholders' equity | $ | 717,323 | $ | 691,585 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
Twelve Months Ended |
|||||||
2021 | 2020 | ||||||
Operating activities: | |||||||
Net income | $ | 56,980 | $ | 38,496 | |||
Adjustments to reconcile net income to cash provided by operating activities: | |||||||
Depreciation and amortization | 42,732 | 47,229 | |||||
Loss on the disposition of capital assets | 3,039 | - | |||||
Stock-based compensation | 1,970 | 879 | |||||
Deferred income tax | 1,785 | (189 | ) | ||||
Other, net | 2,126 | 1,689 | |||||
Changes in assets and liabilities: | |||||||
Increase in accounts receivable | (19,017 | ) | (5,766 | ) | |||
(Increase) decrease in inventory | (31,382 | ) | 6,119 | ||||
(Increase) decrease in other current assets | (1,817 | ) | 2,896 | ||||
Increase in accounts payable | 7,097 | 15,922 | |||||
Increase (decrease) in accrued liabilities | 16,212 | (3,156 | ) | ||||
(Decrease) increase in income taxes payable | (378 | ) | 237 | ||||
Decrease in deferred pension and postretirement benefits | (708 | ) | (2,775 | ) | |||
Increase (decrease) in other long-term liabilities | 477 | (236 | ) | ||||
Other, net | (528 | ) | (549 | ) | |||
Cash provided by operating activities | 78,588 | 100,796 | |||||
Investing activities: | |||||||
Capital expenditures | (24,008 | ) | (25,726 | ) | |||
Proceeds from disposition of capital assets | 5,300 | 502 | |||||
Cash used for investing activities | (18,708 | ) | (25,224 | ) | |||
Financing activities: | |||||||
Borrowings under credit facilities | - | 114,500 | |||||
Repayments of credit facility borrowings | (65,000 | ) | (154,000 | ) | |||
Repayments of other long-term debt | (680 | ) | (1,027 | ) | |||
Common stock dividends paid | (10,779 | ) | (10,534 | ) | |||
Issuance of common stock | 16,272 | 3,626 | |||||
Payroll tax paid to settle shares forfeited upon vesting of stock | (492 | ) | (454 | ) | |||
Purchase of treasury stock | (11,182 | ) | (7,233 | ) | |||
Cash used for financing activities | (71,861 | ) | (55,122 | ) | |||
Effect of exchange rate changes on cash and cash equivalents | 421 | 303 | |||||
(Decrease) increase in cash and cash equivalents | (11,560 | ) | 20,753 | ||||
Cash and cash equivalents at beginning of period | 51,621 | 30,868 | |||||
Cash and cash equivalents at end of period | $ | 40,061 | $ | 51,621 | |||
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | ||||||||||
Three Months Ended |
Twelve Months Ended |
|||||||||
2021 | 2020 | 2021 | 2020 | |||||||
Cash provided by operating activities | ||||||||||
Capital expenditures | (8,002) | (5,053) | (24,008) | (25,726) | ||||||
Free Cash Flow | ||||||||||
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | ||||||||||
As of |
||||||||||
2021 | 2020 | |||||||||
Revolving Credit Facility | ||||||||||
Finance Lease Obligations | 15,537 | 15,321 | ||||||||
Total Debt (1) | 53,537 | 118,321 | ||||||||
Less: Cash and cash equivalents | 40,061 | 51,621 | ||||||||
Net Debt | ||||||||||
(1) Excludes outstanding letters of credit. |
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
Three Months Ended | Three Months Ended | Twelve Months Ended | Twelve Months Ended | ||||||||||||||
Reconciliation of Adjusted Net Income and Adjusted EPS | |||||||||||||||||
Net Income | Diluted EPS | Net Income | Diluted EPS | Net Income | Diluted EPS | Net Income | Diluted EPS | ||||||||||
Net income as reported | |||||||||||||||||
Net Income reconciling items from below | (51) | - | (168) | (0.01) | 1,609 | 0.05 | 2,218 | 0.07 | |||||||||
Adjusted net income and adjusted EPS | |||||||||||||||||
Reconciliation of Adjusted EBITDA | Three Months Ended |
Three Months Ended |
Twelve Months Ended |
Twleve Months Ended |
|||||||||||||
Reconciliation | Reconciliation | Reconciliation | Reconciliation | ||||||||||||||
Net income as reported | |||||||||||||||||
Income tax expense | 5,762 | 4,906 | 23,114 | 11,804 | |||||||||||||
Other, net | (109) | (164) | (754) | (280) | |||||||||||||
Interest expense | 542 | 935 | 2,530 | 5,245 | |||||||||||||
Depreciation and amortization | 10,189 | 11,378 | 42,732 | 47,229 | |||||||||||||
EBITDA | 37,282 | 39,207 | 124,602 | 102,494 | |||||||||||||
EBITDA reconciling items from below | - | 145 | 2,160 | 2,020 | |||||||||||||
Adjusted EBITDA | |||||||||||||||||
Reconciling Items | Three Months Ended |
Three Months Ended |
Twelve Months Ended |
Twleve Months Ended |
|||||||||||||
Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | ||||||||||
Net sales | $ - | $ - | $ - | $ - | |||||||||||||
Cost of sales | 226,818 | - | 189,164 | - | 831,541 | (307) | (1) | 658,750 | - | ||||||||
Selling, general and administrative | 27,668 | - | 26,889 | - | 115,967 | (1,814) | (2) | 89,707 | (1,398) | (2) | |||||||
Restructuring charges | - | - | 145 | (145) | (3) | 39 | (39) | (3) | 622 | (622) | (3) | ||||||
EBITDA | 37,282 | - | 39,207 | 145 | 124,602 | 2,160 | 102,494 | 2,020 | |||||||||
Depreciation and amortization | 10,189 | - | 11,378 | - | 42,732 | - | 47,229 | (968) | (4) | ||||||||
Operating income | 27,093 | - | 27,829 | 145 | 81,870 | 2,160 | 55,265 | 2,988 | |||||||||
Interest expense | (542) | - | (935) | - | (2,530) | - | (5,245) | - | |||||||||
Other, net | 109 | (63) | (5) | 164 | (333) | (5) | 754 | 98 | (5) | 280 | 57 | (5) | |||||
Income before income taxes | 26,660 | (63) | 27,058 | (188) | 80,094 | 2,258 | 50,300 | 3,045 | |||||||||
Income tax expense | (5,762) | 12 | (6) | (4,906) | 20 | (6) | (23,114) | (649) | (6) | (11,804) | (827) | (6) | |||||
Net income | |||||||||||||||||
Diluted earnings per share | |||||||||||||||||
(1) Loss on damage to a plant caused by flooding of |
|||||||||||||||||
(2) Loss on a sale of a plant of |
|||||||||||||||||
(3) Restructuring charges related to the closure of manufacturing plant facilities. | |||||||||||||||||
(4) Accelerated depreciation related to the closure of a North American Cabinet Components plant. | |||||||||||||||||
(5) Foreign currency transaction (gains) losses. | |||||||||||||||||
(6) Impact on a with and without basis. |
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | ||||||||||||||||||||
NA Fenestration | EU Fenestration | NA Components |
Unallocated Corp & Other |
Total | ||||||||||||||||
Three months ended |
||||||||||||||||||||
Net sales | $ | 156,255 | $ | 69,737 | $ | 66,583 | $ | (807 | ) | $ | 291,768 | |||||||||
Cost of sales | 122,078 | 49,402 | 55,718 | (380 | ) | 226,818 | ||||||||||||||
Gross Margin | 34,177 | 20,335 | 10,865 | (427 | ) | 64,950 | ||||||||||||||
Gross Margin % | 21.9 | % | 29.2 | % | 16.3 | % | 22.3 | % | ||||||||||||
Selling, general and administrative | 14,015 | 8,335 | 5,456 | (138 | ) | 27,668 | ||||||||||||||
Depreciation and amortization | 4,202 | 2,602 | 3,298 | 87 | 10,189 | |||||||||||||||
Operating income (loss) | 15,960 | 9,398 | 2,111 | (376 | ) | 27,093 | ||||||||||||||
Depreciation and amortization | 4,202 | 2,602 | 3,298 | 87 | 10,189 | |||||||||||||||
EBITDA | 20,162 | 12,000 | 5,409 | (289 | ) | 37,282 | ||||||||||||||
Adjusted EBITDA | $ | 20,162 | $ | 12,000 | $ | 5,409 | $ | (289 | ) | $ | 37,282 | |||||||||
Adjusted EBITDA Margin % | 12.9 | % | 17.2 | % | 8.1 | % | 12.8 | % | ||||||||||||
Three months ended |
||||||||||||||||||||
Net sales | $ | 141,983 | $ | 56,823 | $ | 57,465 | $ | (866 | ) | $ | 255,405 | |||||||||
Cost of sales | 105,323 | 36,725 | 47,546 | (430 | ) | 189,164 | ||||||||||||||
Gross Margin | 36,660 | 20,098 | 9,919 | (436 | ) | 66,241 | ||||||||||||||
Gross Margin % | 25.8 | % | 35.4 | % | 17.3 | % | 25.9 | % | ||||||||||||
Selling, general and administrative | 12,883 | 6,739 | 5,270 | 1,997 | 26,889 | |||||||||||||||
Restructuring charges | 67 | - | 78 | - | 145 | |||||||||||||||
Depreciation and amortization | 5,243 | 2,423 | 3,593 | 119 | 11,378 | |||||||||||||||
Operating income (loss) | 18,467 | 10,936 | 978 | (2,552 | ) | 27,829 | ||||||||||||||
Depreciation and amortization | 5,243 | 2,423 | 3,593 | 119 | 11,378 | |||||||||||||||
EBITDA | 23,710 | 13,359 | 4,571 | (2,433 | ) | 39,207 | ||||||||||||||
Restructuring charges | 67 | - | 78 | - | 145 | |||||||||||||||
Adjusted EBITDA | $ | 23,777 | $ | 13,359 | $ | 4,649 | $ | (2,433 | ) | $ | 39,352 | |||||||||
Adjusted EBITDA Margin % | 16.7 | % | 23.5 | % | 8.1 | % | 15.4 | % | ||||||||||||
Twelve months ended |
||||||||||||||||||||
Net sales | $ | 578,332 | $ | 251,599 | $ | 246,075 | $ | (3,857 | ) | $ | 1,072,149 | |||||||||
Cost of sales | 450,356 | 172,033 | 211,088 | (1,936 | ) | 831,541 | ||||||||||||||
Gross Margin | 127,976 | 79,566 | 34,987 | (1,921 | ) | 240,608 | ||||||||||||||
Gross Margin % | 22.1 | % | 31.6 | % | 14.2 | % | 22.4 | % | ||||||||||||
Selling, general and administrative | 52,959 | 29,894 | 20,828 | 12,286 | 115,967 | |||||||||||||||
Restructuring charges | 39 | - | - | - | 39 | |||||||||||||||
Depreciation and amortization | 18,730 | 10,373 | 13,263 | 366 | 42,732 | |||||||||||||||
Operating income (loss) | 56,248 | 39,299 | 896 | (14,573 | ) | 81,870 | ||||||||||||||
Depreciation and amortization | 18,730 | 10,373 | 13,263 | 366 | 42,732 | |||||||||||||||
EBITDA | 74,978 | 49,672 | 14,159 | (14,207 | ) | 124,602 | ||||||||||||||
Loss on the damage of a plant | - | 307 | - | - | 307 | |||||||||||||||
Loss on sale of plant | 375 | - | - | 1,439 | 1,814 | |||||||||||||||
Restructuring charges | 39 | - | - | - | 39 | |||||||||||||||
Adjusted EBITDA | $ | 75,392 | $ | 49,979 | $ | 14,159 | $ | (12,768 | ) | $ | 126,762 | |||||||||
Adjusted EBITDA Margin % | 13.0 | % | 19.9 | % | 5.8 | % | 11.8 | % | ||||||||||||
Twelve months ended |
||||||||||||||||||||
Net sales | $ | 483,415 | $ | 161,054 | $ | 210,099 | $ | (2,995 | ) | $ | 851,573 | |||||||||
Cost of sales | 371,811 | 108,781 | 179,804 | (1,646 | ) | 658,750 | ||||||||||||||
Gross Margin | 111,604 | 52,273 | 30,295 | (1,349 | ) | 192,823 | ||||||||||||||
Gross Margin % | 23.1 | % | 32.5 | % | 14.4 | % | 22.6 | % | ||||||||||||
Selling, general and administrative | 47,845 | 22,729 | 18,738 | 395 | 89,707 | |||||||||||||||
Restructuring charges | 295 | - | 327 | - | 622 | |||||||||||||||
Depreciation and amortization | 23,555 | 9,468 | 13,732 | 474 | 47,229 | |||||||||||||||
Operating income (loss) | 39,909 | 20,076 | (2,502 | ) | (2,218 | ) | 55,265 | |||||||||||||
Depreciation and amortization | 23,555 | 9,468 | 13,732 | 474 | 47,229 | |||||||||||||||
EBITDA | 63,464 | 29,544 | 11,230 | (1,744 | ) | 102,494 | ||||||||||||||
Transaction and advisory fees | - | - | - | 55 | 55 | |||||||||||||||
Executive severance charges | - | - | - | 1,343 | 1,343 | |||||||||||||||
Restructuring charges | 295 | - | 327 | - | 622 | |||||||||||||||
Adjusted EBITDA | $ | 63,759 | $ | 29,544 | $ | 11,557 | $ | (346 | ) | $ | 104,514 | |||||||||
Adjusted EBITDA Margin % | 13.2 | % | 18.3 | % | 5.5 | % | 12.3 | % | ||||||||||||
SALES ANALYSIS | |||||||||||||||||
(In thousands) | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||
NA Fenestration: | |||||||||||||||||
$ | 137,825 | $ | 125,522 | $ | 507,634 | $ | 427,616 | ||||||||||
International - fenestration | 8,854 | 9,301 | 34,610 | 28,585 | |||||||||||||
6,991 | 5,500 | 24,534 | 19,279 | ||||||||||||||
International - non-fenestration | 2,585 | 1,660 | 11,554 | 7,935 | |||||||||||||
$ | 156,255 | $ | 141,983 | $ | 578,332 | $ | 483,415 | ||||||||||
EU Fenestration (1): | |||||||||||||||||
International - fenestration | $ | 52,439 | $ | 46,699 | $ | 199,511 | $ | 134,432 | |||||||||
International - non-fenestration | 17,298 | 10,124 | 52,088 | 26,622 | |||||||||||||
$ | 69,737 | $ | 56,823 | $ | 251,599 | $ | 161,054 | ||||||||||
NA Cabinet Components: | |||||||||||||||||
$ | 3,615 | $ | 3,381 | $ | 13,326 | $ | 11,842 | ||||||||||
62,251 | 53,641 | 230,559 | 196,479 | ||||||||||||||
International - non-fenestration | 717 | 443 | 2,190 | 1,778 | |||||||||||||
$ | 66,583 | $ | 57,465 | $ | 246,075 | $ | 210,099 | ||||||||||
Unallocated Corporate & Other: | |||||||||||||||||
Eliminations | $ | (807 | ) | $ | (866 | ) | $ | (3,857 | ) | $ | (2,995 | ) | |||||
$ | (807 | ) | $ | (866 | ) | $ | (3,857 | ) | $ | (2,995 | ) | ||||||
$ | 291,768 | $ | 255,405 | $ | 1,072,149 | $ | 851,573 | ||||||||||
(1) Reflects increase of |
|||||||||||||||||

Source: Quanex Building Products Corporation